Allergic Rhinitis Ppt Powerpoint Presentation slides-Medical Slideshow of allergic rhinitis years History of allergic conjunctivitis of patie

Allergic Rhinitis

Rating :

Rate It:

Send This

Download

Comment

Favourite

more

Notes

Show Notes

Slide 1 :

Allergic Rhinitis Victor A. Agnello, MD Walter Reed Army Medical Center

Slide 2 :

Objectives Understanding what allergic rhinitis is How to recognize allergic rhinitis Treatment

Slide 3 :

Definition Allergic rhinitis (AR) = inflammation of the lining of the nose, characterized by one or more of the following “nasal sx”: Nasal congestion Nasal pruritis Rhinorrhea Sneezing Nasal sx lasting > 1 hr on most days.

Slide 4 :

Prevalence Approx 20% of the US population. Nasal allergies responsible for: 10 million medical office visits 28 million days of restricted activity. 10 million missed work days. 2 million missed school days. Cost for tx = $1.16 billion/yr (1990) Cost due to lost work days = $639 million/yr (1990)

Slide 5 :

Prevalence Males and females equally affected. No apparent ethnic prediliction. Temperate areas of North America and Eurasia.

Slide 6 :

Ages affected Not seen until after age 4 or 5. (Takes approx 3 pollen season exposures). 10-15% in adolescents (adolescents and young adults). Peak age 30 (decades 2, 3 and 4).

Slide 7 :

Ages affected Elderly: Decreased IgE production. Perennial rhinitis rarely caused by allergic mechanisms. Non-allergic (autonomic imbalance, alteration muscarinic receptors, earlier nasal disorder). “Old man’s drip”

Slide 8 :

Predisposition Genetic: Positive FHx (polygenic inheritance) Negative FHx does not rule out dx of AR Atopic dermatitis: Early sign of predisposition to allergy. 13% -/- parent, 30% +/- parent/sibling, 50% +/+ parent. Previous exposure/environmental factors

Slide 9 :

Comorbidities ass’d with AR Asthma Sinusitis Otitis Media (with effusion) (AR occurs frequently in pts with asthma and atopic dermatitis.)

Slide 10 :

Symptoms Direct: Nasal congestion Rhinorrhea Pruritis Sneezing Eye tearing & pruritis Ear & palate pruritis Post nasal drip Anosmia

Slide 11 :

Symptoms Non-nasal: HA Sore throat Chronic cough Mouth breathing

Slide 12 :

Symptoms Psychosocial/Cognitive: Fatigue Depression Irritability Anxiety Sleep disturbance Poor concentration Reduced productivity Impaired learning, decision making and psychomotor speed

Slide 13 :

Anatomy

Slide 14 :

Mechanism Histamine: pruritis, sneezing, rhinorrhea Acetylcholine: stimulates glandular secretion

Slide 15 :

Mediator Effects Vasodilation and increased vascular permeability (nasal congestion) Increased glandular secretion (mucus rhinorrhea) Stimulation of afferent nerves (pruritis & sneezing)

Slide 16 :

Types of Allergic Rhinitis Seasonal (intermittent sx) Perennial (chronic & persistent sx)

Slide 17 :

Seasonal Rhinitis Pollen: Spring (March-June) = Trees Summer (May-August) = Grass Fall (August-October) = Weeds Mold: Spores in outdoors have seasonal variation (reduced #’s in winter, increased in summer/fall due to humidity). House dust mites: Generally a “perennial” allergen, but may be increased in damp autumn months.

Slide 18 :

Perennial Rhinitis Fungi/mold: Exposure peaks accompany activities such as harvesting, cutting grass and leaf raking. Pet Dander (cats, dogs): Can linger up to 4 months after pet removal. House dust mites: Live in bedding, carpets and upholstery. Dietary preference: human epidermal scales. Cockroaches: Respiratory allergy Important allergen in inner-city asthma.

Slide 19 :

Seasonal vs. Perennial Allergic Rhinitis

Slide 20 :

“Rhinitis”: Differential diagnosis Acute Viral Bacterial Chronic Seasonal vs Perennial Chronic infectious rhinosinusitis Nonallergic Vasomotor Gustatory Nonallergic Rhinitis with eosinophilia Primary atrophic Rhinitis medicamentosa Associated with systemic dz Associated with systemic immunological dz Emotional Nasal neoplasm Trauma

Slide 21 :

Diagnosis History Physical exam Skin prick testing, Nasal smear, etc.

Slide 22 :

History General medical hx Rhinological sx (environmental and/or occupational factors) Family Hx Frequency of sx (daily, episodic, seasonal, perennial) Duration Severity (increased, decreased or same) Qualitate nasal discharge: AR: clear and watery Bacterial rhinitis/sinusitis: pus (thick/discolored) Chronic sinusitis: purulent nasal drainage, HA, halitosis.

Slide 23 :

Physical exam Nose Nasal mucosa classically pale blue, but not diagnostic (60%). Thick yellowish secretions suggest infection. Structural deformities that may impede air flow (deviated nasal septum, nasal polypys, hypertrophied turbinates). “Allergic Salute” “Dennie-Morgan” line

Slide 24 :

Eyes “Allergic Shiners” Conjunctivitis Tearing

Slide 25 :

Ears Fluid Infection Lungs Wheezing Persistent coughing Other areas Stigmata of atopic diseases in conjunction with nasal sx: atopic eczema, asthma

Slide 26 :

Skin Prick Testing IgE-mediated rxn (Type I). Small, but significant potentail for anaphylactic rxn. Wheal & flare response (15-20 minutes) Includes a “positive” and “control” soln. Positive rxn = over 3cm wheal with ass’d flare and pruritis (no rxn to neg control).

Slide 27 :

Skin Prick Testing (cont.) # of skin test allergens limited to common aeroallergens in pt’s environment. False positives (dermatographism) False negatives ( interference by meds, i.e. antihistamines)

Slide 28 :

Skin Prick Test (cont.) Discontinue antihistamine use prior to skin testing: Benadryl, CTM: 48 hrs Claritin: 96 hrs Atarax: 120 hrs Hismanal: 6 weeks TCA’s and some antipsychotics may also block skin test results.

Slide 29 :

In vitro serum test (RAST) Serum levels of specific IgE antibodies. Consider in rare pts who: have extensive skin disease have dermatographism must take medication that interferes with skin testing children may prefer blood draw to skin test

Slide 30 :

Nasal smears Eosinophils may help differentiate “allergic” from “infectious” rhinitis (neutrophils).

Slide 31 :

Other diagnostics Peripheral blood eosinophil counts does not assist in allergy diagnosis. Rhinoscopy

Slide 32 :

Medication Arsenal Antihistamines (first and second generation) Decongestants Corticosteroids Cromolyn Sodium Ipratropium

Slide 33 :

AntihistaminesFirst Generation i.e.: Benadryl, Chlor-Trimeton (CTM) Mechanism: inhibition of histamine (H1) receptors. Effect: reduce sneezing, nasal pruritis and rhinorrhea, but not congestion. Note: OTC Work better in “seasonal” rhinitis. Side Effects: anticholinergic activity --> adverse CNS effects.

Slide 34 :

AntihistaminesSecond Generation i.e.: Claritin, Allegra, Zyrtec Mechanism: inhibit histamine (H1) receptors. Effect: same as First generation. Note: Nonsedating (Zyrtec is low-sedating) Prescription only Side effects: Seldane (Terenadine, now off market) -- “Black-box warnings” related with serious cardiac arrhythmias (w/ macrolide, antifungals).

Slide 35 :

Decongestants (oral/topical) i.e.: Sudafed (oral), Afrin (topical) Mechanism: alpha-adrenergic agonist. Effect: vasoconstriction restricts blood flow to nasal mucosa decreasing nasal obstruction (no influence on pruritis, sneezing or nasal secretion). Side effects: Oral: HA, nervousness, irritability, tachycardia, palpitations, insomnia. Topical(nasal): prolonged use (>5-7 days) leads to rhinitis medicamentosa

Slide 36 :

Decongestants Rhinitis Medicamentosa (RM) Prolonged use of topical decongestant may induce rebound congestion upon withdrawal. Leads to inflammatory hypertrophy of nasal mucosa, termed RM. Caused by down regulation of alpha-adrenoreceptors --> less sensitive to endogenously released NE and exogenously applied vasoconstrictors. Tx: wean over 7-10 days while reducing inflammation by intranasal steroids.

Slide 37 :

Corticosteroids (intranasal) i.e.: Vancenase, Flonase Mechanism: reduce inflammation suppress neutrophil chemotaxis mildly vasoconstrictive reduce intracellular edema Effect: reduce nasal blockage, pruritis, sneezing and rhinirrhea.

Slide 38 :

Corticosteroids (continued) Note: most potent single medication for tx of AR. intanasal: acts locally. goal: control sx with lowest possible dose. >90% achieve symptomatic relief. most effective when started several days before exposure and used on regular basis. therapeutic efficacy within 1-3 days, but max efficacy may take up to 3 weeks. compliance is critical. Side effects: nasal irritation, bleeding (nasal septal perforation).

Slide 39 :

Cromolyn Sodium (intranasal) i.e: Nasalcrom Mechanism: mast cell stabilizing agent --> reduces release of histamine and other mediators. Effects: reduces nasal pruritis, sneezing, rhinorrhea and congestion. Note: prophylactic use: start before pollinosis sx or unavoidable/predictable exposures. disadvantage: frequent dosing (q4hrs). Side effects: locally, <10% of pts (sneezing, nasal stinging, burning, irritation).

Slide 40 :

Ipratropium (intranasal) i.e.: Atrovent (intransal) Mechanism: inhibits muscarinic cholinergic receptors. Effect: reduces watery rhinorrhea (no effect on nasal itching, sneezing or nasal congestion). Note: limited to control of watery secretions. effective at reducing both “cold-air” and “gustatory”rhinitis. Side effects: irritation, crusting, epistaxis.

Slide 41 :

Saline (intranasal) i.e.: NaSal, SeaMist, Ocean, Ayr Effects: relief from crusting and can be soothing.

Slide 42 :

Treatment Options 1) Avoidance/modifying factors/patient education bed encasements (allergen-impermeable covers) wash bed sheets @ >130 F dusting/vacuuming air conditioning/filters indoor humidity <40% pets choosing environment explain to pts how meds work

Slide 43 :

Avoidance/Modifying Factors

Slide 44 :

Treatment Options (cont.) 2) Antihistamines +/- Decongestants intermittent AR episodes antihistamines = first line tx (sneezing, pruritis, rhinorrhea) if nasal congestion a major sx, add an oral decongestant. combined tx with antihistamine/decongestant control sx better than with antihistamine alone.

Slide 45 :

Treatment Options (cont.) 3) Add Nasal Steroids prolonged sx add to antihistamine/decongestant regimen will reverse preexisting inflammation will prevent nasal priming

Slide 46 :

Immunotherapy (ITX) Should be considered if: pharmacotherapy insufficiently controls sx or produces undesirable side effects. appropriate avoidance measures fail to control sx. h/o AR for at least 2 seasons (seasonal) or 6 months (perennial). positive skin tests correlate with rhinitis sx.

Slide 47 :

Immunotherapy (cont.) Contraindications: age < 5-6 yrs. use of beta-blockers. contraindication to epinephrine. pt non-compliance. autoimmune dz. induction during pregnancy (maintenance OK). uncontrolled asthma, FEV1<70%

Slide 48 :

Immunotherapy (cont.) 80-85% pts derive long-lasting symptomatic relief. After 3-5 seasons with adequate relief, stopping should be considered. ~60% pts will continue to derive symptomatic benefit with reduced need for medication. All pts on ITX should be encouraged to maintain environmental avoidance and may have to use concomitant medication (i.e.: antihistamines).

Slide 49 :

Who/when to refer to an Allergist The need to assess allergen-specific IgE-mediated mechanisms of sx causation. When pt does not respond to indicated tx (may need rhinoscopy, imaging studies or eval of immunocompetence). Any pt with a treatable complication of allergic dz may benefit from a specialized referral.

Slide 50 :

Patient #1 HPI: 22 yo WM construction worker o/w healthy c/o tearing eyes, excessive sneezing and profuse watery runny nose occurring every spring when he works outdoors. PE: VS: T 97.6, 118/76, HR 60, RR 12 HEENT: no frontal/maxillary sinus tenderness; ocular tearing and scleral injection; TM’s clear; cyanotic/boggy nasal mucosa, thin/clear nasal d/c; oropharynx clear. Lungs: CTAB Skin: no rashes or lesions.

Slide 51 :

Seasonal allergic rhinitis Keys to dx: h/o intermittent sx, related with time of year. PE: ocular tearing, clear “watery” nasal d/c, sneezing. Tx: antihistamine prn or daily use

Slide 52 :

Patient #2 HPI: 19 yo AD BF presents with yellowish nasal d/c x 5 days. She states she initially developed a sore throat and felt fatigued. The sore throat has since resolved. She continues to feel fatigued, and has lost her sense of smell and taste. Denies F/S/C or SOB. PMH: asthma

Slide 53 :

Patient #2 (cont.) PE: VS: T 99.9, 122/80, HR 86, RR 12 HEENT: no frontal/maxillary sinus tenderness; no ocular tearing or scleral injection; TM’s clear; +erythematous nasal nares, nasal mucosa erythematous with mucopurulent d/c; mildly erythematous oropharynx w/o exudates or tonsillar hypertrophy. Neck: mildy tender, shoddy cervical adenopathy. Lungs: mild end expiratory wheezes. No egophany. Skin: no rashes or lesions.

Slide 54 :

Viral vs. Bacterial Rhinitis Keys to dx: Infectious process: mucopurulent nasal d/c, tender cervical lymphadenopathy, low-grade fever, acute process. Tx: if viral rhinitis is suspected: Tylenol, fluids and rest (bacterial superinfection may require additional Abx tx).

Slide 55 :

Patient #3 HPI: 34 yo WM c/o having a “chronic cold”. States his nose is always somewhat congested, with clear d/c. Denies excessive sneezing or ocular tearing. Has been put on CTM in past with minimal success, and has since quit use secondary to feeling sluggish while using.

Slide 56 :

Patient #3 (cont.) PE VS: T 98.6, 124/84, HR 74, RR 14 HEENT: no frontal/maxillary sinus tenderness; sclera non-injected; TM’s clear; transverse crease over lower portion of nose, erythamatous nasal mucosa with scant thin/clear d/c; oropharynx mildly erythematous w/o exudates or tonsillar hypertrophy. Lungs: CTAB Skin: infraorbital cyanosis bilat; papular, lichenified plaques of antecubital fossae bilat.

Slide 57 :

Perennial allergic rhinitis Keys to dx: “Year-round” sx Clear nasal d/c; can see erythematous nasal mucosa in AR. Appears to have co-existent atopic derm. Tx: antihistamine/decongestant + nasal steroid (+ nasal saline). Note: pt would benefit from a non-sedating antihistamine during day. may benefit from skin testing (avoidance, modifying factors).

Slide 58 :

Patient #4 HPI: 38 yo Asian male c/o frontal HA’s, thick yellow nasal d/c, and an occasional productive cough (thick yellowish-green sputum) x 1 week. States that leaning his head forward elicits facial pain/pressure. His wife has commented that he has “bad breath” despite attempts at brushing his teeth. Admits to frequent sinus infections similar to current sx, as well as “year-round” nasal congestion and intermittent d/c, yet that nasal d/c is usually clear. Smokes 1 pack cigarettes/day x 20 yrs.

Slide 59 :

Patient #4 (cont.) PE VS: T 100.1, 134/90, HR 92, RR 18 HEENT: + right maxillary sinus tenderness; right TM mildly injected but w/o effusion; erythematous nasal mucosa with thick green d/c, hypertrophied inferior nasal turbinates bilat; + greenish streaking of posterior oropharynx, + halitosis. Neck: no adenopathy Lungs: CTAB Skin: infraorbital cyanosis; no rashes or lesions.

Slide 60 :

1) Recurrent chronic sinusitis2) Perennial allergic rhinitis Keys to dx: RCS: sinus tenderness, facial pain with leaning forward, mucopurulent nasal d/c, halitosis, h/o perennial allergic rhinitis w/ recurrent sinus infections. Perennial AR: “year-round” nasal congestion w/ clear d/c. Tx: Sinusitis: oral Abx AR: antihistamine, decongestant, nasal steroid, nasal saline, pt education (avoidance, modifying factors). Skin testing. Stop smoking.

Slide 61 :

Questions?

Slide 62 :

There is no comments now for this Slide.

Post a comment

Post Comment on Twitter Post Comment on SlideWorld

Comments:

Subscribe to follow-up comments

	SlidesOnline 1 Years ago. Category: other

Tags:	other

414 Views, 0 favourite
(AR occurs frequently in pts with asthma and atopic dermatitis.) Symptoms. Direct:. Nasal congesti more (AR occurs frequently in pts with asthma and atopic dermatitis.) Symptoms. Direct:. Nasal congestion; Rhinorrhea; Pruritis; Sneezing ... less

SWINE Flu

Why do women live longer then men? Humor

History of Medicine

Yoga and Medicine

How to be a Successful Interventional Fellow size 50 MB

Cardiac Pathology

Hypertension: New Concepts, Guidelines, and Clinical Management

Diabetes Pathology